Cargando…

DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas

BACKGROUND: Glioma is the most common of all primary brain tumors with poor prognosis and high mortality. The 2016 World Health Organization classification of the tumors of central nervous system uses molecular parameters in addition to histology to redefine many tumor entities. The new classificati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paul, Yashna, Mondal, Baisakhi, Patil, Vikas, Somasundaram, Kumaravel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379538/ https://www.ncbi.nlm.nih.gov/pubmed/28392842 http://dx.doi.org/10.1186/s13148-017-0331-9

Ejemplares similares

Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma
por: Paul, Yashna, et al.
Publicado: (2018)

Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma
por: Pal, Jagriti, et al.
Publicado: (2016)

An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals
por: Nijaguna, Mamatha B., et al.
Publicado: (2015)

PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA
por: Nawaz, Zahid, et al.
Publicado: (2016)

Global RNA editome landscape discovers reduced RNA editing in glioma: loss of editing of gamma-amino butyric acid receptor alpha subunit 3 (GABRA3) favors glioma migration and invasion
por: Patil, Vikas, et al.
Publicado: (2020)

S4-KL-1 UPDATE OF WHO2016 CLASSIFICATION OF ADULT DIFFUSE GLIOMAS
por: Komori, Takashi
Publicado: (2019)

Spatial concordance of DNA methylation classification in diffuse glioma
por: Verburg, Niels, et al.
Publicado: (2021)

Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation
por: Brito, Cheila, et al.
Publicado: (2019)

N(6)-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling
por: Visvanathan, Abhirami, et al.
Publicado: (2019)

Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification
por: Kriachok, Iryna, et al.
Publicado: (2022)

DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021)

Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016
por: SASAKI, Hikaru, et al.
Publicado: (2017)

Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing
por: Patil, Vikas, et al.
Publicado: (2015)

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery
por: Cimino, Patrick J., et al.
Publicado: (2017)

Adult type diffuse gliomas in the new 2021 WHO Classification
por: Antonelli, Manila, et al.
Publicado: (2022)

The Erasmus Glioma Database (EGD): Structural MRI scans, WHO 2016 subtypes, and segmentations of 774 patients with glioma
por: van der Voort, Sebastian R., et al.
Publicado: (2021)

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
por: Binder, H., et al.
Publicado: (2019)

Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma
por: Bhargava, Shruti, et al.
Publicado: (2016)

CORRELATION OF CLINICAL FEATURES TO DNA METHYLATION-BASED PROGNOSTIC SUBTYPES IN CHORODOMA PATIENTS
por: Ajisebutu, Andrew, et al.
Publicado: (2023)

Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
por: Pan, XiaoYong, et al.
Publicado: (2019)

IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65
por: Bhargava, Shruti, et al.
Publicado: (2017)

Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns
por: Chen, Xueran, et al.
Publicado: (2019)

Anatomic mapping of molecular subtypes in diffuse glioma
por: Tang, Qisheng, et al.
Publicado: (2017)

Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
por: Gianno, Francesca, et al.
Publicado: (2022)

DNA methylation signatures for breast cancer classification and prognosis
por: Szyf, Moshe
Publicado: (2012)

Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging
por: Hempel, Johann-Martin, et al.
Publicado: (2021)

Classification of Diffuse Glioma Subtype from Clinical-Grade Pathological Images Using Deep Transfer Learning
por: Im, Sanghyuk, et al.
Publicado: (2021)

Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging
por: Liu, Sirui, et al.
Publicado: (2022)

A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
por: Srinivasan, Sujaya, et al.
Publicado: (2011)

Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors
por: Baugh, Joshua N, et al.
Publicado: (2021)

Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2022)

Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas
por: Wang, Zhi-Liang, et al.
Publicado: (2015)

From Theory to Practice: Implementing the WHO 2021 Classification of Adult Diffuse Gliomas in Neuropathology Diagnosis
por: Martin, Karina Chornenka, et al.
Publicado: (2023)

Radiological differences between subtypes of WHO 2016 grade II–III gliomas: a systematic review and meta-analysis
por: van Lent, Djuno I, et al.
Publicado: (2020)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

Subtyping of gliomas of various WHO grades by the application of immunohistochemistry
por: Popova, Svetlana N, et al.
Publicado: (2014)

DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2017)

Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy
por: Chandra, Nagasuma, et al.
Publicado: (2011)

Aggressive lymphoma 2016: revision of the WHO classification
por: Beham-Schmid, Christine
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_21u630qqsl94n27dn68co1uhc9